Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)

SHA:600557 Revenue

In the year 2025, Jiangsu Kanion Pharmaceutical had annual revenue of 3.29B CNY, down -15.52%. Jiangsu Kanion Pharmaceutical had revenue of 950.21M in the quarter ending December 31, 2025, with 20.15% growth.

• Revenue: 3.29B
• Revenue Growth: -15.52%
• P/S Ratio: 2.40
• Revenue / Employee: 537.00K
• Employees: 6,132
• Market Cap: 7.90B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.29B	-604.77M	-15.52%
Dec 31, 2024	3.90B	-966.15M	-19.86%
Dec 31, 2023	4.86B	512.95M	11.79%
Dec 31, 2022	4.35B	702.30M	19.25%
Dec 31, 2021	3.65B	616.64M	20.34%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 29, 2026

Data Sources Report a data error